![Surviving-an-FDA-GCP-Inspection-500.jpg Surviving an FDA GCP Inspection](https://www.centerwatch.com/ext/resources/products/Surviving-an-FDA-GCP-Inspection-500.jpg?height=200&t=1605810958&width=200)
Home » Astellas appoints senior vp of global oncology development
Astellas appoints senior vp of global oncology development
August 6, 2013
Tokyo-based Astellas Pharma Global Development has appointed Claire Thom senior vice president of global oncology development.
Thom has more than 24 years of experience in the pharmaceutical industry across a range of functional areas, including drug development, new product planning and marketing. Most recently, she was senior vice president, portfolio management, drug development management and strategic business operations at Millennium: The Takeda Oncology Company.
Upcoming Events
-
21Oct